The expanding global demand for precision medicine, coupled with the escalating prevalence of cancer and other chronic diseases, is significantly fueling the expansion of the DNA methylation detection technology market. Improvements in sequencing techniques, particularly those offering higher throughput and reduced cost, are further contributing to